In the past few years, multispecific antibodies, such as trispecific, bispecific, and tetraspecific, have become popular in antibody therapeutics. Compared to conventional monospecific antibodies ...

Delhi, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The multispecific antibody market is emerging as a significant area of growth and innovation within the biotechnology and pharmaceutical industries.

Delhi, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Multispecific antibody therapeutics are rapidly emerging as a transformative approach in the treatment of various diseases, particularly cancer ...

The 13 th Annual World Multispecific Summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

Pharmaceutical companies are making investments in research of therapies that target three different antigen-binding sites.

Ichnos launched with a running start in 2019 when it was spun-out as an innovation unit by generics leader Glenmark, and subsequently focused on developing novel multispecific antibody ...

Our complete multispecific antibody development solutions, covering various phases of the development process, such as antibody development and optimization, druggability assessment, animal model ...

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. In this article, we are ...

Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® ...